Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge
- 26 July 2006
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 24 (31-32), 5852-5861
- https://doi.org/10.1016/j.vaccine.2006.04.066
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responsesEuropean Journal of Immunology, 2005
- Secretion of Recombinant Proteins via the Chaperone/Usher Pathway in Escherichia coliApplied and Environmental Microbiology, 2001
- Amphotericin B: new life for an old drugTrends in Pharmacological Sciences, 1996
- Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression systemJournal of General Virology, 1993
- A new gene of the ƒ1 operon of Y. pestis involved in the capsule biogenesisFEBS Letters, 1992
- Expression of the NS1 gene of dengue virus type 2 using vaccinia virusArchiv für die gesamte Virusforschung, 1991
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990
- Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1Journal of General Virology, 1987
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981
- Augmentation of murine immune responses by amphotericin BCellular Immunology, 1977